[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1288 Introduced in House (IH)]
108th CONGRESS
1st Session
H. R. 1288
To amend title XVIII of the Social Security Act to provide for coverage
under the Medicare Program of all oral anticancer drugs.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 13, 2003
Ms. Pryce of Ohio (for herself, Mrs. Myrick, Mr. Greenwood, Mr.
Tancredo, Mr. Houghton, Mr. King of New York, Mr. Goode, Mr. Castle,
Mr. Hyde, Mr. Wamp, Mr. Shuster, Mr. Shimkus, Mr. Portman, Mr.
LaTourette, Mrs. Biggert, Mr. LoBiondo, Mr. Hobson, Mr. Burton of
Indiana, Mr. Tiahrt, Mr. Smith of Michigan, Mr. Wolf, Mr. Bachus, Ms.
DeGette, Mrs. Capps, Mr. Israel, Ms. Lee, Mr. Udall of New Mexico, Mrs.
Maloney, Mr. John, Mr. Green of Texas, Mr. Lipinski, Mr. Pomeroy, Mr.
Turner of Texas, Ms. Baldwin, Mr. Strickland, Mr. Pallone, Mr.
Pascrell, Ms. Berkley, Mr. Holt, Mr. Frost, Mr. Serrano, Mrs. Lowey,
Mr. Murtha, Mr. McIntyre, Mr. Inslee, Mr. Moore, Mr. Carson of
Oklahoma, Mr. Lucas of Kentucky, Mr. Meehan, Mr. George Miller of
California, Mr. Brown of Ohio, and Mr. Burgess) introduced the
following bill; which was referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned
_______________________________________________________________________
A BILL
To amend title XVIII of the Social Security Act to provide for coverage
under the Medicare Program of all oral anticancer drugs.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Access to Cancer Therapies Act of
2003''.
SEC. 2. MEDICARE COVERAGE OF ALL ANTICANCER ORAL DRUGS.
(a) In General.--Section 1861(s)(2)(Q) of the Social Security Act
(42 U.S.C. 1395x(s)(2)(Q)) is amended by striking ``chemotherapeutic
agent for a given indication,'' and all that follows and inserting
``agent for a medically accepted indication (as defined in subsection
(t)(2)(B));''.
(b) Conforming Amendment.--Section 1834(j)(5)(F)(iv) of such Act
(42 U.S.C. 1395m(j)(5)(F)(iv)) is amended by striking ``therapeutic''.
(c) Effective Date.--The amendments made by this section shall
apply with respect to drugs furnished on or after the date that is 90
days after the date of the enactment of this Act.
<all>
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line